BCC Research
View Existing Reports | Report Subscriptions | Upcoming Reports | Press Room
 

Pharmaceuticals

Advanced Drug Delivery Systems: New Developments, New Technologies  

Report Code: PHM006F, Published: October 2006

 

Click here for an updated version:  PHM006G

 
 

REPORT HIGHLIGHTS

  • The U.S. sales of advanced drug delivery systems were over $54.2 billion in 2004. In 2005 they reached $64.1 billion and will eventually grow to $74.4 billion by the end of 2006. Over 5 years, this market will continue to grow at an average annual growth rate (AAGR) of 15.6% to reach $153.5 billion by 2011.
  • The largest sector of the market consists of sustained release/implants/transdermal drug delivery systems, with more than 50% of the total U.S. market in 2005. Through the forecast period this sector will gradually give way to targeted drug delivery systems, which should control almost 48% of the market in 2011.
  • Targeted drug delivery has the highest growth rate, with a 23.3% AAGR through 2011. The next highest are transmucosal drug delivery systems, with 15.3%.

Report Code: PHM006F, Published: October 2006, Analyst: Shalini Shahani

 
 

   Bookmark and Share


   

 Visit the Table of Contents  to purchase the report or to  download the introduction  chapter for free.



All transactions on our web site are conducted on a Secure SSL Server.
Copyright 2010 © All rights reserved.   About Us | Contact Us | Careers | Privacy Policy  |  Site Map |  XML Map